AI Summary
✦ ClarthaValuation Metrics
Trading 35.2% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +1.86). Confidence: 79%.
Live forward EPS implies next-12-month EPS of ₹2.10. Applying the stock's normalized valuation corridor produces a fair range of ₹123.31 to ₹182.51, with base value near ₹158.97 (+269.8% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹2.10
Forward P/E
20.5x
Base Fair Value
₹158.97
Fair Range
₹123.31 - ₹182.51
Upside To Base
+269.8%
Estimate Source
Live forward EPS
Growth Estimate
+88.1%
5Y Average
66.39
Current
102.36
Overvalued
86.91
Undervalued
58.72
5Y Average
15.34
Current
23.64
Overvalued
19.41
Undervalued
12.56
5Y Average
4.10
Current
4.05
Overvalued
4.72
Undervalued
3.49
Peers & Comparison
Sector: Materials · Theme: Specialty Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
NEOGEN CHEMICALS LIMITED NEOGENSpecialty Chemicals | +34.0% | 3.8% | 147.5x Premium | +132% vs avg | +50.8% |
AETHER INDUSTRIES LIMITED AETHERSpecialty Chemicals | +27.5% | 19.1% | 91.7x Premium | +44% vs avg | +116.4% |
ANUPAM RASAYAN INDIA LTD ANURASSpecialty Chemicals | +27.5% | 7.2% | 78.4x Premium | +23% vs avg | +6.7% |
CLEAN SCIENCE & TECH LTD CLEANSpecialty Chemicals | +10.5% | 23.7% | 36.5x Undervalued | -43% vs avg | -30.7% |
SUPREME PETROCHEM LIMITED SPLPETROSpecialty Chemicals | +23.7% | 8.5% | 26.9x Undervalued | -58% vs avg | -4.8% |
GALAXY SURFACTANTS LTD GALAXYSURFSpecialty Chemicals | +14.8% | 5.1% | 27.1x Undervalued | -57% vs avg | -14.4% |
FINE ORGANIC IND. LTD. FINEORGSpecialty Chemicals | +22.1% | 17.8% | 37.6x Undervalued | -41% vs avg | +5.6% |
FINEOTEX CHEMICAL LIMITED trades at a premium (102.4x vs peer avg 63.7x), implying higher growth or quality expectations from the Specialty Chemicals cohort. Peers include NEOGEN CHEMICALS LIMITED, AETHER INDUSTRIES LIMITED, ANUPAM RASAYAN INDIA LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹85 CrJun 2026Latest net profit
₹21 CrJun 2026Latest EPS
₹0.18Jun 2026Net margin
18.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 88 | 104 | 108 | 118 | 107 | 115 | 109 | 108 | 98 | 105 | 96 | 98 | 85 |
| Expenses + | 66 | 76 | 73 | 90 | 80 | 86 | 80 | 88 | 81 | 81 | 75 | 78 | 69 |
| Operating Profit | 22 | 28 | 35 | 29 | 26 | 30 | 30 | 20 | 17 | 23 | 22 | 19 | 16 |
| OPM % | 25% | 27% | 32% | 24% | 25% | 26% | 27% | 19% | 17% | 22% | 23% | 20% | 18% |
| Other Income + | 7 | 8 | 4 | 14 | 4 | 11 | 5 | 8 | 10 | 12 | 11 | 7 | 11 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 28 | 34 | 37 | 41 | 29 | 39 | 32 | 26 | 25 | 33 | 31 | 24 | 24 |
| Tax % | 20% | 20% | 26% | 19% | 24% | 19% | 24% | 24% | 20% | 24% | 17% | 13% | 15% |
| Net Profit + | 23 | 27 | 28 | 33 | 22 | 31 | 24 | 19 | 20 | 25 | 26 | 21 | 21 |
| EPS in Rs | 0.20 | 0.25 | 0.25 | 0.30 | 0.20 | 0.27 | 0.21 | 0.17 | 0.17 | 0.22 | 0.22 | 0.18 | 0.18 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome